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LETTER TO THE EDITOR
Creatinine and cystatin C. There is a lack of studies that compare
endogenous and exogenous GFR markers in ICU patients
ANDERS LARSSON
Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden
Dear Sir,
We appreciate the letter to the Editor by Dr Chia-
Ter Chao regarding our article entitled ‘Signiﬁcant
differences when using creatinine, modiﬁcation of
diet in renal disease, or cystatin C for estimating
glomerular ﬁltration rate in ICU patients’ (1).
Kidneyfunctionisaveryimportantvariableininten-
sive care patients, and we believe that this variable has
not gained sufﬁcient attention. We certainly agree
with the statement that ‘both formulae will not sufﬁce
as good estimators of renal function in critically ill
patients with acute kidney injury’. The problem is
that these two markers are widely analyzed in intensive
care patients and that the results are often used
indiscriminately.
We agree that both markers are subject to interfer-
ence. However, we would like to question the com-
ment that serum cystatin C level is confounded by
inﬂammation status. Several studies have shown an
association between inﬂammation and serum cystatin
C levels, but this may be mediated by kidney damage
induced by inﬂammation. We have in a recently
published study shown that inﬂammation per se
had no effect on cystatin C levels (2).
WethankDrChia-TerChaoforbringinguptheeffect
ofsamplingtimeoncreatinineandcystatinCresults(3).
This is an important aspect that we failed to mention in
our original study. The sampling time may contribute
to the differences, but we ﬁnd the same differences
betweencreatinineandcystatinC-estimatedglomerular
ﬁltration rate (GFR) also in patients who have spent
several days in the intensive care unit (ICU).
The combination of creatinine-based and cystatin
C-based results for estimation of GFR is an interest-
ing approach. However, this strategy is probably most
effective if there is a fair agreement between the two
markers and the mean of the two estimates can be
used. The problem in intensive care patients is that
the differences between the two estimates are pro-
found and that we do not know which of the markers
is correct. We have tried to ﬁnd comparisons in the
literature between creatinine or cystatin C and iohexol
or other exogenous GFR markers in intensive care
patients. To our surprise, we were not able to ﬁnd any
such studies.
We hope that UJMS readers will continue the
discussion on the use of endogenous GFR markers.
Hopefully, this discussion could also lead to the
initiation of studies that compare creatinine/cystatin
C with exogenous GFR markers in intensive care
patients so that in the future we will know how we
should interpret GFR results based on endogenous
GFR markers.
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